Arrow Financial’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,690
Closed -$216K 352
2016
Q4
$216K Sell
2,690
-145
-5% -$11.5K 0.05% 149
2016
Q3
$226K Buy
2,835
+30
+1% +$2.42K 0.06% 148
2016
Q2
$219K Hold
2,805
0.06% 153
2016
Q1
$154K Hold
2,805
0.04% 166
2015
Q4
$173K Hold
2,805
0.05% 153
2015
Q3
$177K Hold
2,805
0.05% 157
2015
Q2
$205K Sell
2,805
-715
-20% -$51.6K 0.06% 159
2015
Q1
$230K Sell
3,520
-455
-11% -$30.3K 0.06% 159
2014
Q4
$259K Sell
3,975
-1,910
-32% -$123K 0.07% 149
2014
Q3
$354K Sell
5,885
-250
-4% -$16.3K 0.1% 149
2014
Q2
$424K Buy
6,135
+200
+3% +$13K 0.11% 148
2014
Q1
$388K Buy
5,935
+4,335
+271% +$282K 0.11% 146
2013
Q4
$99K Hold
1,600
0.03% 183
2013
Q3
$86K Buy
1,600
+500
+45% +$25.8K 0.03% 175
2013
Q2
$50K Buy
+1,100
New +$47.7K 0.02% 184

Other funds holding STJ

Arrow Financial's STJ Position: Q1 2017 in Review

Arrow Financial sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,690 shares — an estimated $216K sold.

Arrow Financial first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $424K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Arrow Financial reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Arrow Financial sold 2,690 St Jude Medical shares in Q1 2017, an estimated $216K.
  • Arrow Financial first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Arrow Financial's St Jude Medical position peaked at $424K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Arrow Financial's 13F filing for Q1 2017, filed 28 Apr 2017.